SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Shares in the human genome—the future of patenting DNA
2 references·4 citing·20 second hop
Shares in the human genome—the future of patenting DNA (2002)Shares in the human genome—the future of …Reforming the Patent System (2000)Reforming the Patent SystemOwnership of the human genome (1996)Ownership of the human genomeIs the Patent System a Barrier to Inclusive Prosperity? The Biomedical Perspective (2019)Is the Patent System a Barrie…Strategic risk management using complementary assets: Organizational capabilities and the commercialization of human genetic testing in the UK (2006)Strategic risk management usi…Policy Conflicts: Gene Patents and Health Care in Canada (2005)Policy Conflicts: Gene Patent…Gene patenting and medical research: a view from a pharmaceutical company (2004)Gene patenting and medical re…Invention, Growth and Welfare: A Theoretical Treatment of Technological Change. (1970)How Broad Should the Scope of Patent Protection Be? (1990)Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Post-Issue Patent "Quality Control": A Comparative Study of US Patent Re-examinations and European Patent Oppositions (2002)The effects of research tool patents and licensing on biomedical innovation (2006)Types of patents and driving forces behind the patent growth in China (2018)Patents in the Knowledge-Based Economy (2003)The price of innovation: new estimates of drug development costs (2003)The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a Dark Corner at the WTO (2002)Effects of Patents and Licenses on the Provision of Clinical Genetic Testing Services (2003)Building on Values: The Future of Health Care in Canada (2005)The Market for "Lemons": Quality Uncertainty and the Market Mechanism (1970)Judgment under Uncertainty: Heuristics and Biases (1974)An Evolutionary Theory of Economic Change. (1983)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Innovation and Patenting within Containerized Liner Shipping (2022)Mapping the broad societal impact of patents (2023)Disease gene patenting is a bad innovation* (1997)Intellectual property rights in transition (1998)DNA Patenting and Licensing (2002)
this work references cited by second hop

References

  • 2000Reforming the Patent System160 cited
  • 1996Ownership of the human genome39 cited

Cited by

  • 2006Strategic risk management using complementary assets: Organizational capabilities and the commercialization of human genetic testing in the UK36 cited
  • 2005Policy Conflicts: Gene Patents and Health Care in Canada16 cited
  • 2019Is the Patent System a Barrier to Inclusive Prosperity? The Biomedical Perspective13 cited
  • 2004Gene patenting and medical research: a view from a pharmaceutical company8 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work